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Abstract – Consumption of food or feed contaminated with fumonisin B1 (FB1), a mycotoxin produced by
Fusarium verticillioides, can lead to disease in humans and animals. The present study was conducted to
examine the effect of FB1 intake on the intestinal immune system. Piglets were used as a target and as a
model species for humans since their gastro-intestinal tract is very similar. The animals were orally exposed
to a low dose of FB1 (1 mg/kg body weight FB1) for 10 days which did not result in clinical signs.
However, when compared to non-exposed animals, FB1-exposed animals showed a longer shedding of F4
+
enterotoxigenic Escherichia coli (ETEC) following infection and a lower induction of the antigen-speciﬁc
immune response following oral immunization. Further analyses to elucidate the mechanisms behind these
observations revealed a reduced intestinal expression of IL-12p40, an impaired function of intestinal antigen
presenting cells (APC), with decreased upregulation of Major Histocompatibility Complex Class II
molecule (MHC-II) and reduced T cell stimulatory capacity upon stimulation. Taken together, these results
indicate an FB1-mediated reduction of in vivo APC maturation.
fumonisin B1 / intestinal APC / F4(K88)+ enterotoxigenic Escherichia coli / mucosal immunization
1. INTRODUCTION
Mycotoxins are secondary fungal metabo-
lites that can be produced in crops and other
food commodities both pre- and post-harvest.
The consumption of contaminated food/feed
can be responsible for diseases in humans and
animals [26, 30]. The fumonisins, which are
produced by Fusarium verticillioides and
related fungi, are among the most widespread
mycotoxins [23]. Different types of fumonisins
have been structurally identiﬁed. The ‘B’ series
include the most prevalent type, the fumonisin
B1 (FB1), which is estimated to contaminate
59% of the corn and corn-based products
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nated moldy sorghum and maize can result in
several human gastro-intestinal disorders [3].
An increased prevalence of neural tube defects
among Mexican-American women is also
attributed to FB1 contamination of the crop har-
vest. Furthermore, fumonisins can cause liver
and kidney toxicity and carcinogenicity, pul-
monary edema and immunosuppression [24].
Their mode of action is not completely under-
stood but they are known to inﬂuence the sphin-
golipid metabolism through the inhibition of
ceramide synthase [11]. Sphingolipids are a
class of membrane lipids which play an impor-
tant role in several cellular mechanisms such as
signal transduction pathways, cell contact,
growth, differentiation and death, and
immunity.
As fumonisins enter the body following con-
sumption of contaminated food/feed, the intes-
tine will be the ﬁrst organ exposed to these
toxins and negative effects of these toxins on
the gastro-intestinal tract have been reported
[9]. In pig, FB1 increases the intestinal coloniza-
tion by pathogenic Escherichia coli [27]. This
could be attributed to the negative impact of
FB1 on the intestinal barrier. Indeed, FB1 alters
the intestinal barrier function by inﬂuencing the
sphingolipid metabolism, as demonstrated by
an increase in the amount of free sphingoid
bases, a depletion of glycolipids in the plasma
membrane and an increase in trans-epithelial
ﬂux [6, 18]. However, an effect of FB1 on the
mucosal immune system could also be involved
in the altered interaction between FB1-exposed
animals and intestinal pathogens. Several stud-
ies demonstrated that FB1 affects the innate
immunity, as well as humoral and cellular
responses from the acquired immunity [2, 7,
21, 24, 38]. It is shown that FB1 decreases
IL-8 expression both in intestinal tissue and in
an intestinal epithelial cell line [8]. Further
information concerning the mode of action of
FB1 on the intestinal immune system is how-
ever needed.
F4
+ enterotoxigenic E. coli (ETEC) adhere
with their F4 ﬁmbriae to F4-speciﬁc receptors
(F4R) on the intestinal epithelium of piglets,
then colonize the small intestine and induce
diarrhea. Following infection, an F4-speciﬁc
immune response is induced within a week
which terminates the F4
+ ETEC excretion
[44]. F4 ﬁmbriae induce a strong mucosal
immunity in piglets. Mucosal immunization of
weaned piglets with puriﬁed F4 ﬁmbriae
induces a potent F4-speciﬁc intestinal immune
response protecting these animals against a sub-
sequent oral challenge with F4
+ ETEC [41].
The F4-mediated adhesion to speciﬁc F4R is
required for this protective F4-speciﬁc immune
response as an oral immunization of F4R-nega-
tive animals fails to induce such an immune
response [42]. In the present study, the F4
model is used to analyze the inﬂuence of FB1
feeding on the porcine intestinal immune
system.
2. MATERIALS AND METHODS
2.1. Experimental design
2.1.1. Animals and housing
Twenty ﬁve conventionally bred pigs (Belgian
Landrace · Pietrain) weaned between 3 and 4 weeks
o fa g ew e r eh o u s e di ni s o l a t i o nu n i t s .T h e yw e r ef e d
ad libitum with a commercial starter diet and treated
orally with colistine, an antibiotic against Gr
- bacte-
ria, for three consecutive days following weaning
(Promycine pulvis, VMD, Berendonk, Belgium,
150 000 U/kg body weight/day) to prevent E. coli
infections which could arise due to handling and
transport of the animals. The piglets were screened
to be F4-seronegative using the F4-speciﬁc ELISA
[41]a sw e l la sF 4 R
+ using the PCR method
described by Rasschaert et al. [33]. The presence of
the F4R was conﬁrmed post-mortem using the
in vitro villous adhesion assay. Adhesion of > 5 bac-
teria per 250 lm villous length was considered as
positive [10]. Males and females were equally
divided in the groups. All animal procedures were
approved by a local ethical committee.
2.1.2. FB1 feeding and allotment
Piglets were randomly divided into a group that
received a FB1-containing fungal extract (n =1 1 )
a n dag r o u pt h a tr e c e i v e dP B S( n =1 4 )( Tab. I).
FB1 was extracted from an in vitro culture of the
Fusarium verticilloides strain NRRL 34281 as previ-
ously described [27]. This crude extract contained
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amounts of zearalenone, fusarochromanone, deoxyni-
valenol or other thrichothecenes. One week after
weaning, FB1 (or PBS) was orally provided at a dose
of 1 mg/kg of body weight/day in 10 mL PBS for 10
days (day -10 until day 0). All animals were weighed
at the beginning and at the end of the administration
period. On day 0, animals were either challenged
with an F4
+ ETEC strain (n = 10), orally immunized
w i t hp u r i ﬁ e dF 4ﬁ m b r i a e( n = 9) or euthanized to
analyze the effects of FB1 on the mucosal immune
system (n =6 ) .
2.2. Experimental infection and immunization
2.2.1. F4
+ ETEC infection
Five piglets of both the FB1 and PBS group were
orally infected with the F4
+ ETEC strain GIS26
(Tab. I). Piglets were sedated with Stresnil (40 mg/
mL; Janssen-Cilag, Berchem, Belgium), after which
the gastric pH was neutralized by intragastric admin-
i s t r a t i o no f6 2m LN a H C O 3 (1.4% (w/v) in distilled
water). Next, 10
10 F4
+ ETEC in 10 mL PBS were in-
tragastrically administered. From day 0 till day 9, the
fecal F4
+ E. coli excretion was daily quantiﬁed by
dot blotting, using the F4-speciﬁc monoclonal anti-
body (mAb) IMM01 as previously described [41].
The prevalence and the severity of diarrhea were
scored blindly according to the visual aspect of the
feces. All piglets were weighed every 3 days from
the start of the FB1 administration till the end of
the F4
+ E. coli excretion.
2.2.2. Oral F4 E. coli immunization
Three animals of both the FB1 and the PBS group
were orally immunized with 2 mg puriﬁed F4 ﬁmb-
riae in 10 mL PBS (FB1+F4 and F4 group respec-
tively) on three subsequent days (day 0–2) (Tab. I).
Three non-exposed animals receiving only PBS
served as negative controls (PBS group). F4 ﬁmbriae
were puriﬁed from strain IMM01 as previously
described [41]. From 3 h before till 2 h after immu-
nization, piglets were deprived of food and water.
One week later (day 7–8), the animals were eutha-
nized by intracardial injection of pentobarbital
(24 mg/kg; Nembutal, Sanoﬁ Sante ´ Animale,
Brussels, Belgium) followed by exsanguination. Sub-
sequently, monomorphonuclear cells (MC) were iso-
lated from the jejunal lamina propria (LP) as
described in Section 2.4.1 and from the mesenteric
lymph node (MLN) and jejunal and ileal Peyer’s
patches (JPP and IPP) as previously described [44].
For each MC suspension, the number of F4-speciﬁc
IgM, IgA and IgG antibody secreting cells (ASC)
were determined as described by Van den Broeck et
al. [42]. Spots in 5 wells (10
6 MC/well) were counted
with an ELIspot reader (Immunospot, CTL) to obtain
t h en u m b e ro fi s o t y p e - s p e c i ﬁ cA S Cp e r5· 10
6 MC.
Table I. Overview of the experimental design and analyses.
25 recently weaned piglets in experiment
Day-10 Control animals 
11 piglets
FB1-treated animals 
14 piglets
Day 0
3 piglets
Slaughter:
FCM
MLR
Cytokines
APC
3 piglets
Oral F4
5 piglets
ETEC 
infection
3 piglets
Slaughter:
FCM
MLR
Cytokines
APC
3 piglets
Oral F4
3 piglets
Oral PBS
5 piglets
ETEC 
infection
Day 7
Slaughter: 
mucosal 
ELISPOT
Slaughter: 
mucosal 
ELISPOT
Slaughter: 
mucosal 
ELISPOT
Day 9
Fecal 
ETEC 
excretion
Fecal 
ETEC 
excretion
FCM: Flow CytoMetry; MLR: Mixed Lymphocyte Reaction; APC: antigen presenting cells.
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Three animals from both the FB1 and the PBS
group were euthanized at day 0 to analyze the inﬂu-
ence of FB1 exposure on the intestinal immune sys-
tem (Tab. I). MC were isolated from MLN, LP, IPP
and JPP (Section 2.2.2).
2.3.1. Intestinal immune cell subpopulations
To analyze whether FB1 feeding inﬂuenced the
number of immune cells in the intestinal mucosa
(T cell populations: CD2
+CD3
+,C D 3
+CD4
+,
CD3
+CD8
+,C D 4
+CD8
+; myeloid cells: CD172
+;B
cells: IgM
+MHC-II
+; antigen presenting cell (APC)
and endothelial cells: IgM
-MHC-II
+), 2.5 · 10
5 cells
were incubated with optimal concentrations of mAbs
(Tab. II) ,w a s h e da n di n c u b a t e dw i t ht h ea p p r o p r i a t e
isotype-speciﬁc FITC- or PE-conjugated antibodies
(Southern Biotech, Birmingham, AL, USA). After a
ﬁnal wash step with ice-cold PBS, 5 nM Sytox
Red (Invitrogen, Merelbeke, Belgium) was added to
allow gating of living cells. Data were acquired on
a FACSCanto ﬂow cytometer (Beckton Dickinson,
Erebodegem, Belgium) with a minimum event count
of 30 000 and analyzed with FACSDiva
  software.
2.3.2. MC proliferative activity
The MC were also functionally characterized by
analyzing their proliferative activity. The cells were
cultured at 5 · 10
5 cells/well in a 96-well culture
plate in leukocyte medium (RPMI-1640, 5% FCS,
1 mM sodium pyruvate (Gibco, Merelbeke,
Belgium), 2 mM L-glutamine (Gibco), 100 lg/mL
kanamycin (Gibco), 50 lg/mL gentamycin (Gibco),
50 lM 2-mercaptoethanol) and subsequently treated
with F4 (20 lg), ﬂagellin (20 lg) or 5 lgo fo n e
of the mitogens concanavalin A (ConA) (Sigma,
Bornem, Belgium), pokeweed mitogen (PWM)
(Sigma) or phytohemagglutinin (PHA) (Sigma) or
left untreated. Flagellin was isolated from the strain
GIS26DFaeG using the same protocol as to purify
F4 ﬁmbriae [46]. Cultures were maintained at
37  Ci nah u m i d i ﬁ e da t m o s p h e r ea t5 %C O 2.A f t e r
72 h the cells were pulse-labeled with 1 lCi [
3H]-
thymidine (Amersham ICN, Bucks, UK) per well
and 18 h later harvested onto glass ﬁber ﬁlters
(Perkin-Elmer, Life Science, Brussels, Belgium).
The incorporated radioactivity was measured using
a b-scintillation counter (Perkin-Elmer).
2.3.3. Cytokine expression by MC
To analyze the inﬂuence of FB1 f e e d i n go nc y t o -
kine expression by intestinal MC, 10
7 cells per sam-
p l ew e r es t o r e da t– 8 0  Ci nT R I z o lR e a g e n t
(Invitrogen) until cDNA synthesis. The amount of
mRNA transcripts from genes encoding cytokines
was measured in triplicates by real-time quantitative
reverse transcriptase-polymerase chain reaction
(qRT-PCR). Brieﬂy, 8 ng cDNA was mixed with
the Power SYBR
  Green PCR Master Mix (Applied
Biosystems, Foster City, CA, USA) and porcine-
speciﬁc primers for housekeeping genes (cyclophilin
A, b2-microglobulin, b-actin) and genes encoding
cytokines (IL-1b, IL-6, IL-12p40, IL-18, TNF-a)
(Tab. III). The reactions were denatured at 95  C
f o r1 0m i nf o l l o w e db y4 0c y c l e so f9 5 Cf o r1 5s
and 60  C for 1 min in the ABI Prism 7000
Sequence Detection System. Data were analyzed
Table II. Overview of the antibodies used in ﬂow cytometry.
Speciﬁcity Name Isotype Reference
CD2 MSA4 IgG2a [29]
CD3 PTT3 IgG1 [49]
CD4 74-12-4 IgG2b [29]
CD8 11/295/33 IgG2a [35]
CD11R1 TMG6-5 IgG1 [13]
CD25 K231.3B2 IgGI [1]
CD80/86 huCTLA-4 muIg fusion protein
(Ancell, Bayport, MN, USA)
IgG2a
CD172 74-22-15 IgG2b [29]
MHC-II MSA3 IgG2a [19]
IgM 28.4.1 IgG1 [43]
hu: human; mu: murine.
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values for cytokine expression were obtained after
normalization to the 3 housekeeping genes (relative
quantiﬁcation).
2.4. Activity of the small intestinal lamina
propria CD11R1
+ cell population
2.4.1. Enrichment of CD11R1
+ cells from jejunal
lamina propia MC
MC were isolated from the LP by collagenase
digestion as previously described [46]. The
peritoneum and muscle layers were stripped off,
after which the intestine was opened along the mes-
enteric side. Subsequently, the remaining tissue was
cut into pieces (1 cm
2) and incubated in a shaking
incubator for 3 · 40 min at 37  C, 150 rpm,
in HBSS-EDTA solution (Ca
2+/Mg
2+-free HBSS
pH 7.2, 0.94 mM DTT (Sigma), 2.52 mM kestranal
(EDTA), 100 U/mL penicillin, 100 lg/mL strepto-
mycin) to remove the epithelium. Next, the tissue
was incubated in a shaking incubator for 30 min at
37  C, 150 rpm in complete medium (RPMI 1640,
5% FCS, 20 mM HEPES (Gibco), 0.1 mg/mL
DNaseI (Roche), penicillin/streptomycin (P/S)) and
subsequently into a collagenase solution (complete
medium, 0.18 U/mL Collagenase A (Sigma)) for
1ha t3 7 C, 120 rpm. The cell suspension was then
ﬁltered through a wire mesh, followed by a 70 lm
cell strainer (Beckton Dickinson), pelleted (400 g,
10 min, 4  C) and resuspended in complete medium
for 10 min at 37  C. Subsequently, the low density
LP MC were enriched by lymphoprep density gradi-
ent centrifugation (Axis-Shield, Oslo, Norway) at
800 g and 18  C for 30 min.
APC were further enriched from the MC fraction
by immunomagnetic separation with the anti-
CD11R1 mAb (Tab. II) and the EasySep
  FITC
selection kit (StemCell Technologies, Grenoble,
France) according to the manufacturer’s instructions.
CD11R1 is recognized by the anti-human CD11b
mAb TMG6-5, which binds the same epitope on
human CD11b and porcine CD11R1. However, the
cellular expression pattern of both molecules differs
greatly, implying a different function of CD11R1 in
pigs [13]. Nonetheless, CD11R1 has previously been
used to characterize porcine APC [4, 50]. The iso-
lated cells were labelledw i t ha n t i - C D 1 1 R 1a n d
FITC-conjugated anti-mouse IgG1 (BD). Subse-
quently, these cells were linked to magnetic nanopar-
ticles using the FITC selection cocktail. To remove
unlabelled cells, the cell suspension was placed in a
EasySep
  magnet for 5 min, after which the superna-
tans was poured off. The retained cells were resus-
pended in PBS/1mM EDTA and the procedure was
repeated to achieve a 90–95% purity of CD11R1
+
LP cells.
Table III. Nucleotide sequences of primers for real-time PCR.
Gene symbol
(gene bank accession number)
Primer sequence Amplicon
size
Cyclophilin A
a F (600 nM) CCCACCGTCTTCTTCGACAT 92
(NM_214353) R (600 nM) TCTGCTGTCTTTGGAACTTTGTCT
b2-microglobulin
a F (900 nM) TTCTACCTTCTGGTCCACACTGA 162
(NM_213978) R (300 nM) TCATCCAACCCAGATGCA
b-actin, [47] F (300 nM) TCATCACCATCGGCAACG 133
(AY550069) R (300 nM) TTCCTGATGTCCACGTCGC
IL-1b
a F (300 nM) GAGCTGAAGGCTCTCCACCTC 87
(NM_001005149) R (300 nM) ATCGCTGTCATCTCCTTGCAC
IL-6
a F (900 nM) TTCACCTCTCCGGACAAAACTG 122
(NM_214399) R (50 nM) TCTGCCAGTACCTCCTTGCTGT
IL-12p40
a F (300 nM) GGTTTCAGACCCGACGAACTCT 112
(NM_214399) R (900 nM) CATATGGCCACAATGGGAGATG
IL-18, [34] F (300 nM) CGTGTTTGAGGATATGCCTGATT 107
(NM_213997) R (300 nM) TGGTTACTGCCAGACCTCTAGTGA
TNF-a,[ 22] F (300 nM) ACTGCACTTCGAGGTTATCGG 118
(NM_214022) R (300 nM) GGCGACGGGCTTATCTGA
a Present study for reference.
FB1 intake inﬂuences mucosal immune system Vet. Res. (2009) 40:40
(page number not for citation purpose) Page 5 of 142.4.2. Phenotypic analysis and Mixed
Lymphocyte Reaction (MLR)
The enriched CD11R1
+ LP cells were cultured in
a2 4 - w e l lp l a t ea t5· 10
5 cells/well in DMEM (Gib-
co), supplemented with 10% FCS, P/S and 20 lg/mL
gentamycin. The cells were stimulated overnight with
50 lg puriﬁed endotoxin-free (AfﬁnityPak Detoxi-
gel; Pierce) F4 or ﬂagellin at 37  Ci nah u m i d i ﬁ e d
atmosphere at 5% CO2. Following stimulation, cells
were analyzed for surface expression of MHC-II
and CD80/86 by ﬂow cytometry as described above.
Gates were set on the CD11R1
+ LPAPC population.
Stimulated CD11R1
+ L Pc e l l sw e r ea l s ou s e da s
stimulator cells in a MLR to analyze their allogeneic
T cell stimulatory capacity as previously described
[5]. Brieﬂy, PBMC were puriﬁed from heparinized
blood samples from an unrelated pig by lymphoprep
density gradient centrifugation. Lymphocytes were
further enriched from the PBMC cell fraction by
depletion of CD172
+ monocytic cells (Tab. II)u s i n g
magnetic cell sorting (MACS system; Miltenyi
Biotec GmbH). CD11R1
+ LP cells were added to
2 · 10
5 lymphocytes at different ratios per well of
a 96-well plate. After 3 days of allogeneic responses,
cocultures were pulsed, harvested and the prolifera-
tion was measured as described above.
2.5. Statistics
Statistical analyses were performed using SPSS
16. Normal distribution of all the data was analyzed
using the Kolmogorov-Smirnov test and tested for
variance homogeneity with the Levine test. The num-
b e ro fF 4
+ E. coli excreted per day, average daily
weight gain, the FCM data and cytokine results were
compared with one-way ANOVA and Bonferroni
adjustment. The ELIspot and the MLR data were ﬁrst
logarithmically transformed to homogenize variances
and then analyzed with a one-way ANOVA and LSD
adjustment to test the effect of FB1 exposure. A two-
way ANOVA (FB1 exposure, day of the experiment)
was used to analyze the effect of the FB1 treatment
on the whole F4
+ E. coli excretion period. A value
of p < 0.05 was considered statistically signiﬁcant.
3. RESULTS
3.1. Oral FB1 intake prolongs intestinal
infection
F4-seronegative and F4R
+ piglets were
infected with F4
+ ETEC to analyze the
inﬂuence of FB1 exposure on an intestinal
infection. The overall shedding of F4
+ E. coli
was higher in the FB1 group (p = 0.040) and
the excretion lasted 2 more days than in the
PBS group (9 versus 7 days) (Fig. 1A). To
examine if this longer shedding could be
attributed to a different F4R expression level,
a villus adhesion test was performed. There
was no difference between FB1-exposed and
control animals in adherence of F4
+ ETEC to
the villi (30 to 89 bacteria per 250 lmv i l l o u s
length for all piglets). The mean consistency
index of the feces was similar for both groups
and the average daily weight gain was not
affected by FB1 before (FB1 group 0.189 ±
0.052 kg/day; PBS group 0.205 ± 0.028
kg/day) or after the F4
+ E. coli infection (FB1
group 0.275 ± 0.063 kg/day; PBS group
0.297 ± 0.053 kg/day). These results show that
consumption of FB1-contaminated feed could
lead to a prolonged intestinal infection.
3.2. Oral FB1 intake reduces the mucosal
immune response
The effects of FB1 exposure on the immune
response of piglets to an F4 mucosal immuniza-
tion were analyzed by enumerating the F4-
speciﬁc ASC (Figs. 1B–1D). One week after
the immunization, signiﬁcant higher numbers
of F4-speciﬁc ASC were found in the F4 group
compared to the PBS group (IgM: MLN
(p = 0.001), JPP (0.001) and the IPP (0.014);
IgA: MLN (0.005), JPP (0.044), IPP (0.001)
and the LP, (0.013); IgG: MLN (0.040) and
IPP (0.023)). Furthermore, immunization of
FB1-exposed animals resulted in signiﬁcant
more F4-speciﬁc ASC compared to the PBS
group (IgM: MLN (p = 0.002), JPP (0.021)
and LP (0.043); IgA: MLN (0.026), JPP
(0.03) and IPP (0.001); IgG: LP (0.043)). These
results indicate that both in the F4 and the
F4+FB1 group an F4-speciﬁc immune response
was mounted. When the F4+FB1 group was
compared to the F4 group, lower numbers of
F4-speciﬁc IgM and IgA ASC were observed
in most tissues. This difference is only signiﬁ-
cant for IgM ASC in the JPP (p =0 . 0 0 3 ) .
Nonetheless, the overall mucosal immune
response(totalnumberofIgAASC,independent
Vet. Res. (2009) 40:40 B. Devriendt et al.
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in the F4+FB1 group compared to the F4
group (p = 0.02), which seems to indicate that
FB1-contaminated feed could have a neg-
ative inﬂuence on the induction of antigen-
speciﬁc immune responses following mucosal
vaccination.
3.3. Modulation of the mucosal immune system
by oral FB1 exposure
To analyze the inﬂuence of FB1 exposure on
the mucosal immune system, MC were isolated
from MLN, LP, IPP and JPP of FB1-exposed
(FB1 group) and non-exposed (PBS group) ani-
mals. The number of B cells, myeloid cells and
speciﬁc T cell populations were identical in
both groups (data not shown). Moreover, the
number of MHC-II
+IgM
- LP MC was not inﬂu-
enced by FB1 treatment (FB1: 18.9% ± 8.5;
PBS: 16.3% ± 6.3). Similarly, their proliferation
following incubation with different mitogens,
F4 ﬁmbriae or ﬂagellin, was not inﬂuenced by
FB1 (data not shown). However, the analysis
of cytokine mRNA by qRT-PCR revealed a sig-
niﬁcant reduction of IL-12p40 expression in the
IPP of FB1-exposed animals (p =0 . 0 2 7 )
(Fig. 2). Furthermore, in the LP both IL-6 and
IL-12p40 mRNA expression were reduced.
The IL-12 cytokine is mainly produced by
APC. Therefore, further experiments were per-
formed to analyze whether FB1 exposure could
inﬂuence intestinal LP APC. Immunomagnetic
enrichment of LP cells routinely yielded
Figure 1. (A) Mean fecal F4
+ E. coli (log 10) per gram feces (± SEM) following F4
+ ETEC infection of
FB1-exposed (FB1, n = 5) and non-exposed animals (PBS, n = 5) at 1 to 9 days post infection (dpi). The
asterisk indicates a signiﬁcant difference (p < 0.05) between both groups. (B) Mean F4-speciﬁc IgM,
(C) IgG and (D) IgA ASCs (± SEM) per 5 · 10
6 MC in lamina propria (LP), mesenteric lymph nodes
(MLN), jejunal (JPP) and ileal Peyer’s patches (IPP) of control animals (PBS, n = 3), F4-immunized
animals (F4, n = 3) and FB1-exposed and F4-immunized animals (F4+FB1, n = 3) at one week following
immunization. Different letters indicate a signiﬁcant difference (p < 0.05) between groups: (a) PBS-F4, (b)
PBS-F4+FB1, (c) F4-F4+FB1.
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consisting of MHC-II
+ APC with contaminat-
ing MHC-II
- eosinophils (Figs. 3A and 3B).
The CD11R1
+MHC-II
+ LPAPC appear to have
a typical dendritic cell morphology (Fig. 3D).
Interestingly, in vivo FB1 exposure had no
inﬂuence on the relative CD11R1
+ eosinophil
or APC percentages in FCM analyses (data
not shown).
In vitro stimulation of CD11R1
+ LP cells
with F4 and the TLR5 ligand ﬂagellin resulted
in a signiﬁcantly increased expression of the
APC maturation markers MHC-II (F4:
p = 0.003 and Flag: 0.001) and CD80/86 (Flag:
p = 0.001) in comparison to unstimulated cells,
implicating CD11R1
+ LP APC in the mucosal
immune response to F4
+ ETEC (Figs. 3C and
3E). Importantly, previous oral exposure of
piglets to FB1 impaired the ability of these
CD11R1
+ LP APC to mature in response to
the mucosal antigens F4 and ﬂagellin. Upregu-
lation of MHC-II in cells from FB1-exposed
animals was reduced in comparison to APC
from the control animals (p = 0.02 and 0.043
respectively), whereas the difference in CD80/
86 expression was not signiﬁcantly, it was how-
ever numerically lower, in the FB1 group
(Fig. 3E). To address a possible inﬂuence of
FB1 on APC function, isolated CD11R1
+ LP
cells were analyzed for their T cell stimulatory
capacity in an allogeneic MLR. The cells were
stimulated overnight with F4 or ﬂagellin and
used as stimulators. Stimulated CD11R1
+ cells
from control animals induced potent T cell
proliferation, whereas previous FB1 exposure
of piglets signiﬁcantly reduced the T cell
Figure 2. The mean fold change of expressed cytokines to a combination of the housekeeping genes
cyclophilin A, b2-microglobulin and b-actin (± SD) in the lamina propria (LP), mesenteric lymph nodes
(MLN), jejunal (JPP) and ileal Peyer’s patches (IPP) of non-exposed animals (PBS, n =3 )o rF B 1-exposed
animals (FB1, n = 3) at the end of the FB1 administration period. The cytokine expression level is
represented in fold change compared to the PBS group (mean value of 1). The asterisk indicates a signiﬁcant
difference (p < 0.05) between both groups.
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Page 8 of 14 (page number not for citation purpose)Figure 3. Increased expression of APC maturation markers MHC-II and CD80/86 on CD11R1
+ LPAPC in
response to stimulation with 50 lg F4. (A) Forward and side scatter characteristics of enriched CD11R1
+
cells, consisting of APC and contaminating eosinophils. (B) Eosinophils do not express APC maturation
markers. (C) Puriﬁed CD11R1
+ cells, gated on the APC population. One representative experiment out of 3
independent experiments is shown. (D) An isolated LP APC stained with anti-CD11R1 TexasRed, anti-
MHC-II FITC and DAPI, bar = 10 lm (E) Mean ﬂuorescence intensity (MFI (± SD)) of isolated CD11R1
+
LP cells stained for CD80/86 and MHC-II expression and gated on the APC population from non-exposed
(PBS, n =3 )o rF B 1-exposed animals (FB1, n = 3) following overnight stimulation with 50 lg F4 (F4) or
ﬂagellin (Flag). The asterisk indicates a signiﬁcant difference (p < 0.05) between both groups; the letters
indicate a signiﬁcant difference between unstimulated (medium) and stimulated cells within groups.
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stimulator or the APC/T cell ratio (Tab. IV).
These data seem to indicate that oral FB1 expo-
sure reduces the maturation of intestinal
CD11R1
+ LP APC.
4. DISCUSSION
The present study shows that despite the
short administration period and the low dose
(1 mg/kg BW/day), which did not result in
any clinical signs or reduced weight gain, oral
FB1 intake prolongs an intestinal ETEC infec-
tion. This appears to agree with previous reports
wherein piglets receiving FB1 orally had an
increased intestinal colonization 48 h following
infection with pathogenic E. coli [27]. We did
not analyze ETEC colonization, but FB1 had
probably no inﬂuence on the intestinal coloni-
zation since the F4R expression level was sim-
ilar on villi of FB1-exposed and non-exposed
animals. Furthermore, based on results of previ-
ous F4
+ ETEC infection experiments, large dif-
ferences in in vivo F4R expression are required
to see differences in F4
+ ETEC colonization
between animals [41, 45]. On the other hand,
FB1 is known to affect the intestinal barrier
[6], cytokine production by enterocytes [8]
and other components of the innate immune
response that are ﬁrst line defense mechanisms
[7]. The latter are involved in the initiation of
the adaptive immunity which seems to be
delayed since the excretion lasted two days
longer in the FB1-exposed piglets. Therefore,
an effect of FB1 on the acquired immune
system could be involved.
It has been shown that FB1 reduces the efﬁ-
ciency of intramuscular vaccination [37].
Accordingly, the present study shows for the
ﬁrst time that a mycotoxin could reduce the
induction of an antigen-speciﬁc intestinal
immune response. In a model with oral F4 im-
munisation, signiﬁcant lower numbers of anti-
gen-speciﬁc IgM ASC were detected in the
JPP of FB1-exposed piglets. Furthermore, both
the F4-speciﬁc IgM and IgA ASC were reduced
after FB1-exposure. This result suggests that
FB1 could interfere with the induction phase
of the immune response, especially since the
overall mucosal IgA immune response was sig-
niﬁcantly reduced in FB1-exposed piglets. The
adaptive immune system needs around 3 to 5
days to induce an F4-speciﬁc immune response
and the ﬁrst F4-speciﬁc ASC that appear in the
intestine are mainly F4-speciﬁc IgM ASC that
Table IV. The stimulation index of proliferated allogeneic lymphocytes after coculture with graded numbers
of CD11R1
+ LP cells, consisting of APC and eosinophils, isolated from FB1-exposed and non-exposed
animals.
APC stimulation Mean stimulation index p-value
APC/T cell ratio Control animals FB1-treated animals
F4 stimulation
1/10 38.60 ± 6.18 1.33 ± 0.75 < 0.05
1/30 13.12 ± 1.16 1.10 ± 0.07 < 0.001
1/90 17.92 ± 2.20 0.97 ± 0.09 < 0.01
1/270 6.63 ± 1.41 0.95 ± 0.71 0.08
Flagellin stimulation
1/10 71.92 ± 15.94 2.84 ± 1.64 < 0.05
1/30 30.30 ± 5.54 1.65 ± 0.20 < 0.01
1/90 41.02 ± 8.28 1.13 ± 0.46 < 0.01
1/270 9.84 ± 2.99 0.86 ± 0.33 < 0.05
Mean ± SD (n = 3). CD11R1
+ cells were incubated overnight with either F4 or ﬂagellin to induce activation. The
SI was calculated by dividing the individual cpm values of every condition by the mean cpm value of the control
coculture (untreated CD11R1
+ cells and lymphocytes). SI from both negative controls, CD11R1
+ cells and
lymphocytes alone, were lower than 1.5.
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no indications that FB1 inﬂuences IgA synthe-
sis, in contrast to the mycotoxins deoxynivale-
nol (DON) and nivalenol which selectively
stimulate IgA production in porcine Peyer’s
patches [31].
Dendritic cells (DC) have a central position
in the mucosal immune system by connecting
innate and acquired immune responses. In the
LP, DC take up antigens and migrate to the
MLN where they interact with T cells. Binding
of pathogen-associated molecular patterns to
pathogen recognition receptors triggers DC
maturation and enables them to induce effector
T cell responses. DC maturation is character-
ized by an increased expression of MHC-II
and co-stimulatory molecules like CD40,
CD80 and CD86 and the secretion of polariz-
ing cytokines like IL-10 and IL-12 [16]. After
in vivo FB1-exposure, we observed a reduced
transcription of IL-12p40 by MC, although
restricted to the intestinal IPP, which suggests
an effect of FB1 on APC since these cells
are the main producers of this cytokine [39].
Here we found that CD11R1
+ LP APC from
control animals upregulated MHC-II and
CD80/86 expression in response to F4 and
Flag stimulation. On the contrary, CD11R1
+
LP APC from FB1-exposed animals had a
reduced upregulation of MHC-II expression.
We also observed a tendency of FB1 to reduce
the upregulation of CD80/86 expression. Both
ﬁndings indicate that intestinal CD11R1
+ APC
from FB1-exposed piglets are less responsive
to F4 and Flag stimulation. This contradicts
results obtained with human MoDC, where
the expression of CD86 was not modulated
by FB1 treatment [36].
These data suggest that FB1 could affect the
maturation of LP APC. A hallmark of mature
DC is their ability to induce T cell proliferation
due to increased expression of MHC-II and
costimulatory molecules, such as CD80/86
[40]. Although a mixed population of
CD11R1
+ APC and eosinophils was used to
investigate the T cell stimulatory capacity, the
obtained results were consistent with the
MHC-II and CD80/86 expression. We show
for the ﬁrst time that F4 and ﬂagellin enhance
the T cell stimulatory capacity of porcine intes-
tinal CD11R1
+ APC. Moreover, we demon-
strate that in vivo FB1 exposure of piglets
resulted in an impaired Tcell stimulatory capac-
ity of intestinal CD11R1
+ LP APC. To our
knowledge, this has not been previously dem-
onstrated. On the contrary, Bimczok et al. [5]
did not observe a reduced ability of porcine
MoDC to induce T cell proliferation after
treatment with DON, despite the reduced
expression of MHCII, CD40 and CD80/86.
This discrepancy could be explained by the
type of mycotoxin itself or the cell type used
as APC model. The possibility that the
observed reduction in functional APC matura-
tion is due to an effect of FB1 on CD11R1
+
APC or eosinophil migration seems unlikely
since we observed no difference between FB1-
exposed and control animals in the number of
isolated CD11R1
+ cells, in the relative percent-
age of CD11R1
+ APC or eosinophils or in the
percentage of MHC-II
+IgM
- LP APC. The
small intestinal LP MC contains mainly 2
MHC-II
+ cell populations, APC and endothelial
cells [15]. Although we cannot discriminate
between these populations in this study, the
number of endothelial cells should remain con-
stant irrespective of FB1 exposure. Although
APC migration does not seem to be affected
by FB1, the latter could still inﬂuence the func-
tion of CD11R1
- LPAPC. However, it has been
demonstrated that only the CD11R1
+ LP APC
migrate from the LP to the MLN [4], suggesting
that these cells are functionally the most rele-
vant APC with respect to the induction of a pri-
mary immune response.
Despite the small numbers of animals, we
report for the ﬁrst time an effect of a mycotoxin
on intestinal APC maturation. The reduced mat-
uration of FB1-exposed intestinal APC could
explain the longer F4
+ ETEC excretion and
the lower F4-speciﬁc immune response to oral
F4 immunization in FB1-exposed animals.
Other effects of FB1 on the acquired immune
system are reported like inﬂux of immune cells
[32, 38] or altered Tcell proliferation following
mitogen stimulation [17, 21]. In the present
study FB1 exposure did not alter these parame-
ters in the porcine intestine.
The observed negative impact of FB1 on the
immune system could be a threat for the health
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this study could be extrapolated to man since
the gastro-intestinal tract of both species share
a lot of similarities [12]. This stresses the need
to further develop methods to reduce the con-
sumption of FB1-contaminated food [48],
which is common in developing countries
where the prevalence of several infectious dis-
eases is high [20, 25]. The negative impact of
FB1 on the mucosal immune system can sup-
port the emergence of infectious diseases and
suggests that the efﬁciency of vaccination pro-
grams would be increased with a concomitant
reduction of FB1 intake by the local population.
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